$10.960
-0.030 (-0.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARDT Prediction & Forecast by Similar Chart Analysis
Alphio's ARDT stock price prediction model matches the current Ardent Health Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.99 (+0.30%). The 1-week path is $11.04 (+0.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ardent Health Inc Stock?
Currently, Ardent Health Partners Inc is trading at $10.96, which is below the average analyst price target of $13.67. The forward P/E ratio is 10.70, indicating a potentially attractive valuation. However, the recent earnings report showed a GAAP EPS of $0.12, missing expectations by $0.05, which raises concerns about profitability. The RSI is at 46.56, suggesting the stock is nearing oversold territory, but is not yet a strong buy signal. The main risk is the 1-year change of -13.50%, indicating significant volatility and potential for further declines.
ARDT stock price ended at $10.96 on Friday, after losing -0.27%
Ardent Health Inc (ARDT) last closed at $10.96, losing -0.27%. These facts feed the 1-day and 1-week ARDT price prediction above.
Forecast Drivers
Ardent Health Inc (ARDT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARDT, ranked by similarity.
Seasonality analysis for ARDT
Historically the probability of a positive August return for ARDT is 60.32%. August offers the highest probability of a positive month at 60.32%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.